Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer - Poll - MDSpire

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer

  • By

  • Giulia Sapuppo

  • Marco Russo

  • Grete Francesca Privitera

  • Michele Massimino

  • Sebastiano Piana

  • Maria Antonietta Trovato

  • Giusi Blanco

  • Davide Adinolfi

  • Giorgia Romano

  • Gabriella Pellegriti

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer

  • by Giulia Sapuppo, Marco Russo, Grete Francesca Privitera, Michele Massimino, Sebastiano Piana, Maria Antonietta Trovato, Giusi Blanco, Davide Adinolfi, Giorgia Romano, Gabriella Pellegriti

  • June 11, 2026

Related Content

Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer

Editorial: Integrating nutrition in cancer therapy: approaches to improve patient outcomes and survival

Spatial immune archetypes in gastric and colorectal cancer: a proposed conceptual framework for immunotherapy resistance and therapeutic remodeling